"Designing Growth Strategies is in our DNA"
Spinal stenosis is among the most common health complications affecting a large portion of population in developed as well as developing countries. Interspinous spacers are the devices implanted between the vertebral spinous processes. These implants aim to restrict the painful motion while otherwise enabling normal motion. They distract the laminar space and/or spinous processes to restrict extension. The rising geriatric population with increasing cases of lumber spinal stenosis is anticipated to drive the market growth during the forecast period. For instance, according to World Health Organisation (WHO), the world’s population aged 60 years and above is expected to reach 2 billion by 2050, up from 900 million in 2015. Moreover, other factors such as higher adoption of minimally invasive surgeries, rising awareness regarding interspinous spacers among the population, technological advancements, and numerous product launches by the key players are projected to fuel the market growth in the upcoming years.
The overall interspinous spacers market is expected to witness significant growth during the forecast period due to factors such as growing geriatric population with rise in spinal stenosis, increase higher adoption of minimally invasive surgeries, and numerous product launches by key players. However, complications associated with interspinous spacers such as higher risk of repeat surgery is one of the major factor anticipated to restrict the interspinous spacers market.
Key Market Driver -
Growing geriatric population with spinal stenosis, higher adoption of minimally invasive surgeries
Key Market Restraint -
Complications associated with interspinous spacers
Globally, the interspinous spacers market can be segmented on the bases of the product, indication, end-user, and region. Based on the product the market can be segmented into static (non-compressible spacers) and dynamic (compressible spacers). Based on the indication, the market can be segmented into lumber spinal stenosis, degenerative disc diseases, and others. Based on the end-users, the market can be segmented into hospitals, ambulatory surgery centers, orthopedic clinics, and others. Geographically, the interspinous spacers market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
Some of the major companies that are present in the interspinous spacers market are Medtronic, NuVasive, Inc., RTI Surgical Holdings, Inc., Zimmer Biomet, Boston Scientific Corporation, Life Spine, Inc., Globus Medical, and other prominent players.
Geographically, the interspinous spacers market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is likely to dominate the interspinous spacers market owing to the rising geriatric population with cases of lumber spinal stenosis. For instance, according to article published by AME Medical Journal, in 2017, it is estimated that more than 200,000 adults suffered from lumber spinal stenosis in U.S. and it is estimated to raise up to 64 million elderly adults by 2025. Europe is projected to hold second largest market share throughout the forecast period. The development of new products and partnership activities of major market players is likely to boost the growth of the interspinous spacers market in this region. Additionally, the rising geriatric population and higher adoption of minimally invasive surgeries also drives the growth of market in this region. However, Asia Pacific is expected to grow with the highest CAGR due to an increasing prevalence of lumber spinal stenosis and other degenerative disc diseases among the geriatric population.
To gain extensive insights into the market, Request for Customization
On the other hand, the market in Latin America and the Middle East & Africa is anticipated to have a lucrative market growth during the forecast period owing to the rising patient demand for minimally invasive surgeries growing governmental and non-governmental initiatives for improving the healthcare.
ATTRIBUTE | DETAILS |
By Product |
|
By Indication |
|
By End User |
|
By Geography |
|
US +1 833 909 2966 ( Toll Free )